DRREDDYPharmaceuticals
Dr Reddys Laboratories Ltd — Quarterly Results & Earnings
₹1254.90
-1.46%
Profit Growth YoY7.28%Latest quarter
Sales Growth YoY9.83%Latest quarter
Sales CAGR 5Y13.26%5 year compound
Profit CAGR 5Y22.28%5 year compound
📋
Quarterly Performance
YoY Profit Growth+7.28%
📈 Moderate growth
YoY Sales Growth+9.83%
📈 Moderate growth
OPM 5Y Average
24.30%Operating profit margin
EPS Growth 5Y
22.17%Interest Coverage
24.46Higher = safer debt servicing
ROE
17.96%ROCE
22.69%💡
Growth Analysis
Dr Reddys Laboratories Ltd reported YoY profit growth of 7.28% and revenue growth of 9.83% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 13.26% and profits at 22.28% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Dr Reddys Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.